Oxbridge Re earnings matched, revenue fell short of estimates
Oxbridge Re (OXBR) reported Q3 EPS of $-0.05, matching estimates, but revenue of $261K missed the $400K consensus. The stock closed at $0.90, down 31.15% over 3 months and 36.52% over 12 months. InvestingPro rates its financial health as 'fair performance'.
How this was made
The 30-second read
Why it matters
The earnings miss is the first public disclosure of the quarter's results, making it a primary news event for the stock.
Market read
The earnings miss is likely to drive short‑term downside for OXBR, with limited spillover to the broader market.
What to watch
The report does not mention any guidance or upcoming contract pipeline that could mitigate the revenue shortfall.
Background
Oxbridge Re (NASDAQ: OXBR) is a micro‑cap reinsurance firm. The article provides its Q3 earnings numbers and a brief performance summary.
Ticker impact
Oxbridge Re reported Q3 EPS of -$0.05 and revenue of $261K, missing the $400K consensus estimate.
downward pressure as investors price in the revenue shortfall
The earnings release shows a material revenue miss versus expectations, which historically leads to price declines for micro‑cap stocks.
Market effects
Limited; the miss reflects challenges for niche reinsurance players but does not shift broader sector outlook.
Minimal; Oxbridge Re is a U.S. micro‑cap with negligible effect on regional indices.
None
Counterpoint
If the company can secure new reinsurance contracts, the short‑term miss may be a buying opportunity.
Key entities
- companyOxbridge Re
NASDAQ‑listed reinsurance company reporting Q3 results.


